Abstract Significant tricuspid regurgitation (TR) is seen as a relevant contributor of cardiac morbidity and mortality. Transcatheter tricuspid valve replacement
Transcatheter heart valves technologies
Transcatheter heart valves technologies
SGLT2-inhibitors in diabetic patients with severe aortic stenosis and cardiac damage undergoing transcatheter aortic valve implantation (TAVI)
Abstract Background A substantial number of patients with severe aortic stenosis (AS) undergoing transcatheter aortic valve implantation (TAVI) experience adverse
Transcatheter heart valves technologies
Association Between Direct Oral Anticoagulant Score and Bleeding Events in Patients With Atrial Fibrillation Following Transcatheter Aortic Valve Replacement: A Retrospective Multicenter Cohort Study
Abstract Background The Direct Oral Anticoagulant (DOAC) Score can predict bleeding risk in patients with atrial fibrillation taking DOACs; however,
Transcatheter heart valves technologies
Pacemaker Implantation for Low‐Grade Conduction Abnormalities After Balloon‐Expandable Transcatheter Aortic Valve Implantation
Abstract Introduction A frequent complication after TAVI are postinterventional conduction abnormalities requiring permanent pacemaker implantation. In this study, we analyzed
Transcatheter heart valves technologies
Lipoprotein(a) and High‐Sensitivity C‐Reactive Protein Compound the Risk of Hypoattenuating Leaflet Thickening After Transcatheter Aortic Valve Replacement
Abstract Background The mechanism for hypoattenuating leaflet thickening (HALT) after transcatheter aortic valve replacement is still not well elucidated, and
Transcatheter heart valves technologies
Successful management of acute left main coronary occlusion following transcatheter aortic valve implantation: a case report
Abstract Background Transcatheter aortic valve implantation is an established, highly effective procedure in selected patients with severe degenerative aortic valve
Transcatheter heart valves technologies
Impact of prior hospitalization for heart failure on clinical outcomes of patients after transcatheter aortic valve implantation with new‐generation devices: Insights from the LAPLACE‐TAVI registry
Abstract Background A history of hospitalization for heart failure (HHF) before transcatheter aortic valve implantation (TAVI) or surgical aortic valve
Transcatheter heart valves technologies
Recovery rate from conduction disorders in patients with permanent pacemaker implantation after transcatheter aortic valve implantation
Abstract Backgrounds Permanent pacemaker implantation (PPMI) is one of the greatest disadvantages of transcatheter aortic valve implantation (TAVI). To seek
Transcatheter heart valves technologies
Elevated myocardial extracellular volume fraction as a new predictor of conduction defects after transcatheter aortic valve replacement
Abstract Key points Transcatheter aortic valve replacement (TAVR) is now the standard of care for patients with severe symptomatic aortic
